熔点	121.5-122.0 ºC**
沸点	241.3±40.0 ºC (760 Tor
闪点	99.7±27.3 ºC, 计算值*
密度	1.335±0.06 g/cm3 (20 º

没有数据	没有数据

来源	SDS样本
没有数据	没有数据

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

Immune-mediated drug-induced liver disease.Zhang-Xu Liu et al.Clinics in liver disease, 6(3), 755-774 (2002-10-05) Coupling Laser Diode Thermal Desorption with Acoustic Sample Deposition to Improve Throughput of Mass Spectrometry-Based Screening.Zuzana Haarhoff et al.Journal of biomolecular screening, 21(2), 165-175 (2015-10-01) Drug Interactions for Low-Dose Inhaled Nemiralisib: A Case Study Integrating Modeling, In Vitro, and Clinical Investigations.Aarti Patel et al.Drug metabolism and disposition: the biological fate of chemicals, 48(4), 307-316 (2020-02-06) Toxicity and Synergistic Activities of Chalcones Against Aedes aegypti (Diptera: Culicidae) and Drosophila melanogaster (Diptera: Drosophilidae).Aaron D Gross et al.Journal of medical entomology, 54(2), 382-386 (2016-12-25) Enzyme Kinetics and Molecular Docking Studies on Cytochrome 2B6, 2C19, 2E1, and 3A4 Activities by Sauchinone.Eun Chae Gong et al.Molecules (Basel, Switzerland), 23(3) (2018-03-03) Effect of ticrynafen on aqueous humor dynamics in monkeys.M A Croft et al.Archives of ophthalmology (Chicago, Ill. : 1960), 116(11), 1481-1488 (1998-11-21) Characterisation of artemisinin-chloroquinoline hybrids for potential metabolic liabilities.Roslyn Thelingwani et al.Xenobiotica; the fate of foreign compounds in biological systems, 46(3), 234-240 (2015-09-05) Evaluation of time-dependent cytochrome P450 inhibition using cultured human hepatocytes.Dermot F McGinnity et al.Drug metabolism and disposition: the biological fate of chemicals, 34(8), 1291-1300 (2006-05-09) Involvement of cytochrome P450-mediated metabolism in tienilic acid hepatotoxicity in rats.Takayoshi Nishiya et al.Toxicology letters, 183(1-3), 81-89 (2008-11-11) A novel approach to cyclin-dependent kinase 5/p25 inhibitors: A potential treatment for Alzheimer's disease.Mahendra Ramesh Shiradkar et al.Bioorganic & medicinal chemistry, 15(19), 6397-6406 (2007-07-24) In Vitro Assessment of Potential for CYP-Inhibition-Based Drug-Drug Interaction Between Vonoprazan and Clopidogrel.Mitsuhiro Nishihara et al.European journal of drug metabolism and pharmacokinetics, 44(2), 217-227 (2018-10-27) Toxicity and Synergistic Activities of Chalcones Against Aedes aegypti (Diptera: Culicidae) and Drosophila melanogaster (Diptera: Drosophilidae).Aaron D Gross et al.Journal of medical entomology, 54(2), 382-386 (2016-12-25) Enzyme Kinetics and Molecular Docking Studies on Cytochrome 2B6, 2C19, 2E1, and 3A4 Activities by Sauchinone.Eun Chae Gong et al.Molecules (Basel, Switzerland), 23(3) (2018-03-03) Drug Interactions for Low-Dose Inhaled Nemiralisib: A Case Study Integrating Modeling, In Vitro, and Clinical Investigations.Aarti Patel et al.Drug metabolism and disposition: the biological fate of chemicals, 48(4), 307-316 (2020-02-06) Cytochromes P450 as targets to autoantibodies in immune mediated diseases.E Boitier et al.Molecular aspects of medicine, 20(1-2), 84-137 (1999-11-27) Physicochemical and drug metabolism characterization of a series of 4-aminoquinoline-3-hydroxypyridin-4-one hybrid molecules with antimalarial activity.Roslyn Thelingwani et al.Expert opinion on drug metabolism & toxicology, 10(10), 1313-1324 (2014-09-16) Comparative NMR-based metabonomic investigation of the metabolic phenotype associated with tienilic acid and tienilic acid isomer.Muireann Coen et al.Chemical research in toxicology, 25(11), 2412-2422 (2012-09-28) Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose.R Scott Obach et al.Chemical research in toxicology, 21(9), 1814-1822 (2008-08-12) Comparison of the substrate specificities of human liver cytochrome P450s 2C9 and 2C18: application to the design of a specific substrate of CYP 2C18.C Minoletti et al.Biochemistry, 38(24), 7828-7836 (1999-07-01) Electrospray ionization mass spectrometric analysis of intact cytochrome P450: identification of tienilic acid adducts to P450 2C9.L L Koenigs et al.Biochemistry, 38(8), 2312-2319 (1999-02-25) Metabolism of a 5HT6 Antagonist, 2-Methyl-1-(Phenylsulfonyl)-4-(Piperazin-1-yl)-1H-Benzo[d]imidazole (SAM-760): Impact of Sulfonamide Metabolism on Diminution of a Ketoconazole-Mediated Clinical Drug-Drug Interaction.Aarti Sawant-Basak et al.Drug metabolism and disposition: the biological fate of chemicals, 46(7), 934-942 (2018-04-27) Markers of electrophilic stress caused by chemically reactive metabolites in human hepatocytes.Hideo Takakusa et al.Drug metabolism and disposition: the biological fate of chemicals, 36(5), 816-823 (2008-01-30) Kinetics of tienilic acid bioactivation and functional generation of drug-protein adducts in intact rat hepatocytes.M Pilar López-García et al.Biochemical pharmacology, 70(12), 1870-1882 (2005-11-01) Preclinical evaluation of the potential for cytochrome P450 inhibition and induction of the selective ALK inhibitor, alectinib.Nobuo Sekiguchi et al.Xenobiotica; the fate of foreign compounds in biological systems, 47(12), 1042-1051 (2016-11-15) Identification of protein targets of reactive metabolites of tienilic acid in human hepatocytes.Yakov M Koen et al.Chemical research in toxicology, 25(5), 1145-1154 (2012-04-03) The substrate binding site of human liver cytochrome P450 2C9: an NMR study.S Poli-Scaife et al.Biochemistry, 36(42), 12672-12682 (1997-10-23) Direct and quantitative evaluation of the major human CYP contribution (fmCYP) to drug clearance using the in vitro Silensomes™ model.Yannick Parmentier et al.Xenobiotica; the fate of foreign compounds in biological systems, 49(1), 22-35 (2018-01-04) Effects of novel ethacrynic acid derivatives on human trabecular meshwork cell shape, actin cytoskeletal organization, and transcellular fluid flow.Ponugoti Vasantha Rao et al.Biological & pharmaceutical bulletin, 28(12), 2189-2196 (2005-12-06) A strategy for early-risk predictions of clinical drug-drug interactions involving the GastroPlusAnna-Karin Sohlenius-Sternbeck et al.Xenobiotica; the fate of foreign compounds in biological systems, 48(4), 348-356 (2017-04-27) The crucial protective role of glutathione against tienilic acid hepatotoxicity in rats.Takayoshi Nishiya et al.Toxicology and applied pharmacology, 232(2), 280-291 (2008-08-19) Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid.Armelle Melet et al.Archives of biochemistry and biophysics, 409(1), 80-91 (2002-12-05) Tienilic acid enhances hyperbilirubinemia in Eisai hyperbilirubinuria rats through hepatic multidrug resistance-associated protein 3 and heme oxygenase-1 induction.Takayoshi Nishiya et al.Toxicological sciences : an official journal of the Society of Toxicology, 91(2), 651-659 (2006-03-18) Drug-induced immunotoxicity.P M Dansette et al.European journal of drug metabolism and pharmacokinetics, 23(4), 443-451 (1999-05-14) Differential oxidation of two thiophene-containing regioisomers to reactive metabolites by cytochrome P450 2C9.Peter M Rademacher et al.Chemical research in toxicology, 25(4), 895-903 (2012-02-15) Is uric acid really an independent cardiovascular risk factor?D G Beevers et al.Lancet (London, England), 352(9139), 1556-1556 (1998-11-20) Establishment of a novel hepatocyte model that expresses four cytochrome P450 genes stably via mammalian-derived artificial chromosome for pharmacokinetics and toxicity studies.Daisuke Satoh et al.PloS one, 12(10), e0187072-e0187072 (2017-10-25) Development of an in vitro system with human liver microsomes for phenotyping of CYP2C9 genetic polymorphisms with a mechanism-based inactivator.Darcy R Flora et al.Drug metabolism and disposition: the biological fate of chemicals, 40(4), 836-842 (2011-12-30) Use of isotopes and LC-MS-ESI-TOF for mechanistic studies of tienilic acid metabolic activation.M Belghazi et al.Advances in experimental medicine and biology, 500, 139-144 (2002-01-05) Quantitative Chemical Proteomic Profiling of the in Vivo Targets of Reactive Drug Metabolites.Landon R Whitby et al.ACS chemical biology, 12(8), 2040-2050 (2017-06-22)

备注